JACQUALYN A FOUSE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JACQUALYN A FOUSE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JACQUALYN A FOUSE. JACQUALYN A FOUSE is see remarks in CELGENE CORP /DE/ ($CELG) and Director in INCYTE CORP ($INCY) and Director in DICKS SPORTING GOODS INC ($DKS) and Chief Executive Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in PERRIGO Co plc ($PRGO).
Latest Insider Trading Transactions of JACQUALYN A FOUSE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CELG, DKS, INCY, PRGO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 81.27 | 251 | 20,399 | 5,510 | 5.3 K to 5.5 K (+4.77 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,333 | 0 | 22,667 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 3,398 | 0 | 58,363 | 61.8 K to 58.4 K (-5.50 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 11,333 | 0 | 61,761 | 50.4 K to 61.8 K (+22.47 %) |
Jan 05 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 86.98 | 237 | 20,614 | 5,259 | 5 K to 5.3 K (+4.72 %) |
Jan 05 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 86.98 | 237 | 20,614 | 5,259 | 5 K to 5.3 K (+4.72 %) |
Oct 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 89.74 | 219 | 19,653 | 5,022 | 4.8 K to 5 K (+4.56 %) |
Oct 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 89.74 | 219 | 19,653 | 5,022 | 4.8 K to 5 K (+4.56 %) |
Jul 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 103.97 | 202 | 21,002 | 4,803 | 4.6 K to 4.8 K (+4.39 %) |
May 28 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
May 28 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 1,282 | 0 | 4,601 | 3.3 K to 4.6 K (+38.63 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,379 | 0 | 24,759 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 40.64 | 3,673 | 149,271 | 50,428 | 54.1 K to 50.4 K (-6.79 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 12,379 | 0 | 54,101 | 41.7 K to 54.1 K (+29.67 %) |
Apr 02 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 73.23 | 270 | 19,772 | 3,319 | 3 K to 3.3 K (+8.86 %) |
Mar 24 2020 | DKS | DICK'S SPORTING GO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 9,518 | 0 | 55,288 | 45.8 K to 55.3 K (+20.80 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 51.51 | 137,000 | 7,056,870 | 137,000 | |
Nov 15 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | P | 31.00 | 40,322 | 1,249,982 | 41,722 | 1.4 K to 41.7 K (+2,880.14 %) |
Jul 02 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 84.96 | 203 | 17,247 | 2,580 | 2.4 K to 2.6 K (+8.54 %) |
Jul 02 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 84.96 | 203 | 17,247 | 2,580 | 2.4 K to 2.6 K (+8.54 %) |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
Apr 29 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
Apr 29 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 1,520 | 0 | 2,377 | 857 to 2.4 K (+177.36 %) |
Apr 05 2019 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 4,181 | 0 | 45,770 | 41.6 K to 45.8 K (+10.05 %) |
Apr 02 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 86.01 | 145 | 12,471 | 857 | 712 to 857 (+20.37 %) |
Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,695 | 0 | 42,695 | |
Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 53.87 | 350,346 | 18,873,139 | 350,346 | |
Jan 03 2019 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 63.59 | 196 | 12,464 | 712 | 516 to 712 (+37.98 %) |
Oct 02 2018 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 69.08 | 180 | 12,434 | 516 | 336 to 516 (+53.57 %) |
Jul 03 2018 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 67.00 | 186 | 12,462 | 336 | 150 to 336 (+124.00 %) |
May 03 2018 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 60.85 | 15,000 | 912,750 | 15,000 | |
Apr 05 2018 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 4,732 | 0 | 41,589 | 36.9 K to 41.6 K (+12.84 %) |
Apr 03 2018 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 83.33 | 150 | 12,500 | 150 | 0 to 150 |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Director | Option Exercise | A | 61.17 | 16,000 | 978,720 | 16,000 | |
Nov 16 2017 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 105.12 | 8,750 | 919,800 | 8,750 | |
Nov 16 2017 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Option Exercise | A | 105.12 | 25,000 | 2,628,000 | 25,000 | |
Jun 22 2017 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Option Exercise | M | 27.13 | 20,000 | 542,600 | 0 | |
Jun 22 2017 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Buy | M | 27.13 | 20,000 | 542,600 | 36,857 | 16.9 K to 36.9 K (+118.65 %) |
Apr 05 2017 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 3,261 | 0 | 16,857 | 13.6 K to 16.9 K (+23.98 %) |
Feb 16 2017 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 0.00 | 16,322 | 0 | 16,322 | |
Jan 31 2017 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 113.18 | 18,543 | 2,098,697 | 18,543 | |
Dec 06 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
Dec 06 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 117.63 | 2,352 | 276,666 | 82,040 | 84.4 K to 82 K (-2.79 %) |
Dec 06 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Buy | M | 0.00 | 5,000 | 0 | 84,392 | 79.4 K to 84.4 K (+6.30 %) |
Nov 02 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 102.18 | 18,543 | 1,894,724 | 18,543 | |
Aug 01 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 114.69 | 18,543 | 2,126,697 | 18,543 | |
May 06 2016 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Option Exercise | M | 0.00 | 924 | 0 | 0 | |
May 06 2016 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Payment of Exercise | F | 95.70 | 444 | 42,491 | 3,916 | 4.4 K to 3.9 K (-10.18 %) |
May 06 2016 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Buy | M | 95.70 | 924 | 88,427 | 4,360 | 3.4 K to 4.4 K (+26.89 %) |
May 03 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 0.00 | 9,755 | 0 | 9,755 | |
May 03 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 104.97 | 18,543 | 1,946,459 | 18,543 | |
May 03 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | M | 0.00 | 11,000 | 0 | 0 | |
May 03 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 103.41 | 5,177 | 535,354 | 79,392 | 84.6 K to 79.4 K (-6.12 %) |
May 03 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Buy | M | 0.00 | 11,000 | 0 | 84,569 | 73.6 K to 84.6 K (+14.95 %) |
Apr 05 2016 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 2,336 | 0 | 13,596 | 11.3 K to 13.6 K (+20.75 %) |
Feb 16 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 102.45 | 13,746 | 1,408,278 | 73,569 | 87.3 K to 73.6 K (-15.74 %) |
Feb 16 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Grant | A | 0.00 | 29,219 | 0 | 87,315 | 58.1 K to 87.3 K (+50.29 %) |
Feb 02 2016 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 100.80 | 8,625 | 869,400 | 8,625 | |
Dec 18 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
Dec 18 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 0.00 | 8,482 | 0 | 8,482 | |
Dec 18 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 112.17 | 3,532 | 396,184 | 58,079 | 61.6 K to 58.1 K (-5.73 %) |
Dec 18 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Buy | M | 0.00 | 7,500 | 0 | 61,611 | 54.1 K to 61.6 K (+13.86 %) |
Nov 17 2015 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Option Exercise | M | 0.00 | 1,929 | 0 | 0 | |
Nov 17 2015 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Payment of Exercise | F | 146.90 | 926 | 136,029 | 3,436 | 4.4 K to 3.4 K (-21.23 %) |
Nov 17 2015 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Buy | M | 146.90 | 1,929 | 283,370 | 4,362 | 2.4 K to 4.4 K (+79.28 %) |
Nov 10 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 114.08 | 8,625 | 983,940 | 8,625 | |
Nov 06 2015 | PRGO | PERRIGO Co plc | FOUSE JACQUALYN A | Director | Option Exercise | A | 0.00 | 924 | 0 | 924 | |
Jul 29 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 132.56 | 8,625 | 1,143,330 | 8,625 | |
May 04 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
May 04 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | A | 109.90 | 8,625 | 947,888 | 8,625 | |
May 04 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | M | 0.00 | 11,200 | 0 | 0 | |
May 04 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 108.06 | 5,292 | 571,854 | 54,111 | 59.4 K to 54.1 K (-8.91 %) |
May 04 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Buy | M | 0.00 | 11,200 | 0 | 59,403 | 48.2 K to 59.4 K (+23.24 %) |
Apr 07 2015 | DKS | DICKS SPORTING GOO ... | FOUSE JACQUALYN A | Director | Grant | A | 0.00 | 1,881 | 0 | 11,260 | 9.4 K to 11.3 K (+20.06 %) |
Mar 03 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Option Exercise | M | 0.00 | 8,334 | 0 | 0 | |
Mar 03 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Payment of Exercise | F | 121.53 | 3,937 | 478,464 | 48,203 | 52.1 K to 48.2 K (-7.55 %) |
Mar 03 2015 | CELG | CELGENE CORP /DE/ | FOUSE JACQUALYN A | see remarks | Buy | M | 0.00 | 8,334 | 0 | 52,140 | 43.8 K to 52.1 K (+19.02 %) |
Page: 1